Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva S Istvan

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Elife|March 20, 2019
<i>Plasmodium</i> Niemann-Pick type C1-related protein is a druggable target required for parasite membrane homeostasisEva S Istvan, Sudipta Das, Suyash Bhatnagar, et al.
Cell Chemical Biology|December 10, 2019
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug DiscoveryJames M Murithi, Edward S Owen, Eva S Istvan, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2018
Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial proteaseJeffrey P Chance, Hannah Fejzic, Obiel Hernandez, et al.
ACS Infectious Diseases|March 15, 2021
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>Frances Rocamora, Purva Gupta, Eva S Istvan, et al.
Science Advances|December 18, 2024
The <i>Plasmodium falciparum</i> NCR1 transporter is an antimalarial target that exports cholesterol from the parasite's plasma membraneZhemin Zhang, Meinan Lyu, Xu Han, et al.
ACS Infectious Diseases|March 15, 2023
Human Polo-like Kinase Inhibitors as AntiplasmodialsMonica J Bohmer, Jinhua Wang, Eva S Istvan, et al.
Nature Communications|May 7, 2026
Cellular and molecular basis of PfCoronin function in artemisinin resistance in Plasmodium falciparumImran Ullah, Madeline A Farringer, Malhar Khushu, et al.
ACS Infectious Diseases|September 15, 2021
Prioritization of Molecular Targets for Antimalarial Drug DiscoveryBarbara Forte, Sabine Ottilie, Andrew Plater, et al.
Trends in Parasitology|March 2, 2021
MalDA, Accelerating Malaria Drug DiscoveryTuo Yang, Sabine Ottilie, Eva S Istvan, et al.
Science Translational Medicine|March 8, 2023
Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug targetEva S Istvan, Francisco Guerra, Matthew Abraham, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Elife|March 20, 2019
<i>Plasmodium</i> Niemann-Pick type C1-related protein is a druggable target required for parasite membrane homeostasisEva S Istvan, Sudipta Das, Suyash Bhatnagar, et al.
Cell Chemical Biology|December 10, 2019
Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug DiscoveryJames M Murithi, Edward S Owen, Eva S Istvan, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2018
Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial proteaseJeffrey P Chance, Hannah Fejzic, Obiel Hernandez, et al.
ACS Infectious Diseases|March 15, 2021
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>Frances Rocamora, Purva Gupta, Eva S Istvan, et al.
Science Advances|December 18, 2024
The <i>Plasmodium falciparum</i> NCR1 transporter is an antimalarial target that exports cholesterol from the parasite's plasma membraneZhemin Zhang, Meinan Lyu, Xu Han, et al.
ACS Infectious Diseases|March 15, 2023
Human Polo-like Kinase Inhibitors as AntiplasmodialsMonica J Bohmer, Jinhua Wang, Eva S Istvan, et al.
Nature Communications|May 7, 2026
Cellular and molecular basis of PfCoronin function in artemisinin resistance in Plasmodium falciparumImran Ullah, Madeline A Farringer, Malhar Khushu, et al.
ACS Infectious Diseases|September 15, 2021
Prioritization of Molecular Targets for Antimalarial Drug DiscoveryBarbara Forte, Sabine Ottilie, Andrew Plater, et al.
Trends in Parasitology|March 2, 2021
MalDA, Accelerating Malaria Drug DiscoveryTuo Yang, Sabine Ottilie, Eva S Istvan, et al.
Science Translational Medicine|March 8, 2023
Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug targetEva S Istvan, Francisco Guerra, Matthew Abraham, et al.
Pageof 3